We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
+21.74%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$209M
AUM Growth
–
Cap. Flow
+$171M
Cap. Flow %
81.86%
Top 10 Hldgs %
19.72%
Holding
99
New
99
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EXAM
EXAMWORKS GROUP INC COM STK (DE)
EXAM
+$3.91M
2
PRLB icon
Protolabs
PRLB
+$3.71M
3
ACHC icon
Acadia Healthcare
ACHC
+$3.69M
4
CSOD
Cornerstone OnDemand, Inc.
CSOD
+$3.38M
5
GTLS
Chart Industries
GTLS
+$3.29M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Industrials 17.38%
2 Technology 16.51%
3 Healthcare 16.42%
4 Consumer Discretionary 14.34%
5 Financials 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RRTS
76
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$1.08M 0.52%
+1,423
New +$906K
ATHN
77
DELISTED
Athenahealth, Inc.
ATHN
$1.06M 0.51%
+9,490
New +$849K
SONC
78
DELISTED
Sonic Corp
SONC
$1.04M 0.5%
+67,670
New +$900K
PCRX icon
79
Pacira BioSciences
PCRX
$1.06B
$1.02M 0.49%
+30,035
New +$869K
ALGN icon
80
Align Technology
ALGN
$12.2B
$1.01M 0.48%
+23,420
New +$807K
IPHI
81
DELISTED
INPHI CORPORATION
IPHI
$1M 0.48%
+86,005
New +$870K
CNC icon
82
Centene
CNC
$30B
$991K 0.47%
+71,480
New +$867K
FIVE icon
83
Five Below
FIVE
$12.2B
$983K 0.47%
+25,290
New +$942K
SWFT
84
DELISTED
Swift Transportation Company
SWFT
$924K 0.44%
+51,820
New +$795K
BWLD
85
DELISTED
Buffalo Wild Wings, Inc.
BWLD
$888K 0.43%
+8,575
New +$804K
QLIK
86
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$874K 0.42%
+27,910
New +$769K
LRN icon
87
Stride
LRN
$3.56B
$843K 0.4%
+27,110
New +$726K
SSYS icon
88
Stratasys
SSYS
$706M
$835K 0.4%
+9,415
New +$759K
DECK icon
89
Deckers Outdoor
DECK
$13.5B
$802K 0.38%
+87,690
New +$796K
ECYT
90
DELISTED
Endocyte, Inc. Common Stock
ECYT
$667K 0.32%
+37,100
New +$500K
ICPT
91
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$636K 0.3%
+13,585
New +$464K
ANN
92
DELISTED
ANN INC
ANN
$630K 0.3%
+18,585
New +$564K
SN
93
DELISTED
Sanchez Energy Corporation
SN
$616K 0.3%
+26,060
New +$530K
ANGI icon
94
Angi Inc
ANGI
$228M
$606K 0.29%
+2,753
New +$641K
XONE
95
DELISTED
The ExOne Company
XONE
$596K 0.29%
+9,770
New +$412K
SBGI icon
96
Sinclair Inc
SBGI
$989M
$553K 0.26%
+19,620
New +$512K
EPZM
97
DELISTED
Epizyme, Inc
EPZM
$453K 0.22%
+12,555
New +$323K
RM icon
98
Regional Management Corp
RM
$301M
$451K 0.22%
+14,586
New +$334K
SBNY
99
DELISTED
Signature Bank
SBNY
$303K 0.15%
+3,310
New +$255K
1 2 3
4

Similar funds

GF
Gray Foundation Cohoes, New York $397M AUM 32.69% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
ECA
Elevated Capital Advisors Sandy, Utah $397M AUM 11.67% 1-Year Est. Return
DL
Dockside LLC New York $397M AUM
STT
Singapore Technologies Telemedia Singapore $396M AUM 59.06% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return

Lisanti Capital Growth's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Lisanti Capital Growth, which disclosed 99 positions worth $209M. Its ten largest holdings account for 20% of the portfolio.

Its largest position is EXAMWORKS GROUP INC COM STK (DE): 208,495 shares worth $5.06M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, followed by Technology and Healthcare.

  • Lisanti Capital Growth's largest Q2 2013 buy was EXAMWORKS GROUP INC COM STK (DE): 208,495 shares worth $5.06M.
  • Lisanti Capital Growth's ten largest holdings make up 20% of its $209M portfolio in Q2 2013.
  • Lisanti Capital Growth disclosed 99 positions in Q2 2013, its first 13F filing on record.

Based on Lisanti Capital Growth's 13F filing for Q2 2013, filed 6 Aug 2013.